Gilda Padalino
Swansea, WLS SA28PP, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Hedera helix-derived α-hederin (IVL-11) demonstrates both ex vivo and in vivo flukicidal activities against Fasciola hepatica.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 04, 2025
Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms.
Journal: MicrobiologyOpen
Published: July 22, 2024
Quinoxaline-Based Anti-Schistosomal Compounds Have Potent Anti-Malarial Activity.
Journal: bioRxiv : the preprint server for biology
Published: May 07, 2024
Quinoxaline-based anti-schistosomal compounds have potent anti-plasmodial activity.
Journal: PLoS pathogens
Published: April 23, 2024
Small Molecule Ligands of the BET-like Bromodomain, SmBRD3, Affect Schistosoma mansoni Survival, Oviposition, and Development.
Journal: Journal of medicinal chemistry
Published: December 04, 2023
Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022.
Journal: ACS infectious diseases
Published: April 21, 2023
Using ChEMBL to Complement Schistosome Drug Discovery.
Journal: Pharmaceutics
Published: March 22, 2023
Chemical modulation of Schistosoma mansoni lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changes.
Journal: Wellcome open research
Published: March 10, 2023
Structural Investigations on Novel Non-Nucleoside Inhibitors of Human Norovirus Polymerase.
Journal: Viruses
Published: November 25, 2022
Identification of anti-schistosomal, anthelmintic and anti-parasitic compounds curated and text-mined from the scientific literature.
Journal: Wellcome open research
Published: July 08, 2022
Last Updated: 09/26/2026